Adipokine chemerin overexpression in trophoblasts leads to dyslipidemia in pregnant mice: implications for preeclampsia

[1]  Chi-Hung Lin,et al.  Stomatin modulates adipogenesis through the ERK pathway and regulates fatty acid uptake and lipid droplet growth , 2022, Nature Communications.

[2]  Jibo He,et al.  Acetyl-CoA Carboxylases and Diseases , 2022, Frontiers in Oncology.

[3]  Qing Yang,et al.  Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms , 2022, Clinical science.

[4]  T. Sakurai,et al.  Lysophosphatidylethanolamine Affects Lipid Accumulation and Metabolism in a Human Liver-Derived Cell Line , 2022, Nutrients.

[5]  S. Pfisterer,et al.  Low-Density Lipoprotein Internalization, Degradation and Receptor Recycling Along Membrane Contact Sites , 2022, Frontiers in Cell and Developmental Biology.

[6]  E. Gratacós,et al.  The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics , 2022, Life.

[7]  Kecheng Zhang,et al.  Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy , 2021, Frontiers in Endocrinology.

[8]  S. Elmore,et al.  Histology Atlas of the Developing Mouse Placenta , 2021, Toxicologic pathology.

[9]  M. Nangaku,et al.  Lysophosphatidylcholine mediates fast decline in kidney function in diabetic kidney disease , 2021, Kidney International.

[10]  S. Subramaniam,et al.  The maternal blood lipidome is indicative of the pathogenesis of severe preeclampsia , 2021, Journal of lipid research.

[11]  Zhenyu Li,et al.  Assessment of Biphasic Extraction Methods of Mouse Fecal Metabolites for Liquid Chromatography-Mass Spectrometry-Based Metabolomic Studies. , 2021, Journal of proteome research.

[12]  M. Kurano,et al.  Lysophosphatidylinositol, especially albumin‐bound form, induces inflammatory cytokines in macrophages , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  N. Saito,et al.  Structurally different lysophosphatidylethanolamine species stimulate neurite outgrowth in cultured cortical neurons via distinct G-protein-coupled receptors and signaling cascades. , 2020, Biochemical and biophysical research communications.

[14]  G. Orlando,et al.  Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases , 2020, Frontiers in Physiology.

[15]  A. Khaire,et al.  Placental lipid metabolism in preeclampsia , 2020, Journal of hypertension.

[16]  G. Fink,et al.  Chemerin contributes to in vivo adipogenesis in a location-specific manner , 2020, PloS one.

[17]  A. Khairani,et al.  Differences in expression of Peroxisome Proliferator-activated Receptor-γ in early-onset preeclampsia and late-onset preeclampsia , 2020, BMC Research Notes.

[18]  N. Chandel,et al.  Mitochondrial TCA cycle metabolites control physiology and disease , 2020, Nature Communications.

[19]  S. Pennathur,et al.  Prenatal testosterone excess disrupts placental function in a sheep model of polycystic ovary syndrome. , 2019, Endocrinology.

[20]  P. Damm,et al.  Gestational diabetes mellitus , 2019, Nature Reviews Disease Primers.

[21]  S. Karumanchi,et al.  Preeclampsia: Pathophysiology, Challenges, and Perspectives , 2019 .

[22]  C. Buechler,et al.  Chemerin Isoforms and Activity in Obesity , 2019, International journal of molecular sciences.

[23]  ACOG Practice Bulletin No. 202 Summary: Gestational Hypertension and Preeclampsia. , 2019, Obstetrics and gynecology.

[24]  P. Laudanski,et al.  Role of dyslipidemia in preeclampsia-A review of lipidomic analysis of blood, placenta, syncytiotrophoblast microvesicles and umbilical cord artery from women with preeclampsia. , 2018, Prostaglandins & other lipid mediators.

[25]  A. Fish,et al.  Lysophosphatidic acid produced by autotaxin acts as an allosteric modulator of its catalytic efficiency , 2018, The Journal of Biological Chemistry.

[26]  G. Helfer,et al.  Chemerin: a multifaceted adipokine involved in metabolic disorders , 2018, The Journal of endocrinology.

[27]  A. Davenport,et al.  International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function , 2018, Pharmacological Reviews.

[28]  C. Simón,et al.  Severe pre-eclampsia is associated with alterations in cytotrophoblasts of the smooth chorion , 2017, Development.

[29]  Chunze Zhang,et al.  Role of the lipid-regulated NF-κB/IL-6/STAT3 axis in alpha-naphthyl isothiocyanate-induced liver injury , 2016, Archives of Toxicology.

[30]  C. Okerberg,et al.  The Application of Paraphenylenediamine Staining for Assessment of Phospholipidosis , 2016, Toxicologic pathology.

[31]  Xiaoming Yang,et al.  Modulation of FABP4 hypomethylation by DNMT1 and its inverse interaction with miR-148a/152 in the placenta of preeclamptic rats and HTR-8 cells. , 2016, Placenta.

[32]  L. Jianhua,et al.  Research Article Open Access Expression and Clinical Significance of Lxrα and Srebp-1c in Placentas of Preeclampsia , 2022 .

[33]  P. Scherer,et al.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. , 2016, Cell metabolism.

[34]  B. Madison.  Srebp2: A master regulator of sterol and fatty acid synthesis1 , 2016, Journal of Lipid Research.

[35]  M. Dong,et al.  Increased expression of fatty acid binding protein 4 in preeclamptic Placenta and its relevance to preeclampsia. , 2016, Placenta.

[36]  G. Aksan,et al.  Chemerin as an independent predictor of cardiovascular event risk , 2016, Therapeutic advances in endocrinology and metabolism.

[37]  P. Barter,et al.  Dysfunctional HDL and atherosclerotic cardiovascular disease , 2016, Nature Reviews Cardiology.

[38]  A. Tall,et al.  SORTILIN: many headed hydra. , 2015, Circulation research.

[39]  S. Gambhir,et al.  Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. , 2014, The Journal of clinical investigation.

[40]  Jennifer G. Robinson,et al.  Systematic Reviews and Meta-and Pooled Analyses Maternal Hyperlipidemia and the Risk of Preeclampsia : A Meta-Analysis , 2014 .

[41]  E. L. Arrese,et al.  Lipid Droplets as Signaling Platforms Linking Metabolic and Cellular Functions , 2014, Lipid insights.

[42]  P. Stone,et al.  Is ethnicity a risk factor for developing preeclampsia? An analysis of the prevalence of preeclampsia in China , 2014, Journal of Human Hypertension.

[43]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[44]  Haiyan Xu,et al.  Hepatic ERK activity plays a role in energy metabolism , 2013, Molecular and Cellular Endocrinology.

[45]  C. Albrecht,et al.  Increased Placental Phospholipid Levels in Pre-Eclamptic Pregnancies , 2013, International journal of molecular sciences.

[46]  V. Aidinis,et al.  Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. , 2013, Biochimica et biophysica acta.

[47]  Douglas B. Kell,et al.  The metabolome of human placental tissue: investigation of first trimester tissue and changes related to preeclampsia in late pregnancy , 2012, Metabolomics.

[48]  M. Fasshauer,et al.  Serum levels of the adipokine chemerin are increased in preeclampsia during and 6months after pregnancy , 2011, Regulatory Peptides.

[49]  Mi-kyung Kim,et al.  Relationship between Chemerin Levels and Cardiometabolic Parameters and Degree of Coronary Stenosis in Korean Patients with Coronary Artery Disease , 2011, Diabetes & metabolism journal.

[50]  Y. Sadovsky,et al.  Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. , 2011, The Journal of clinical endocrinology and metabolism.

[51]  C. Hellerbrand,et al.  Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. , 2011, Endocrinology.

[52]  G. Bejerano,et al.  Noninvasive Monitoring of Placenta-Specific Transgene Expression by Bioluminescence Imaging , 2011, PloS one.

[53]  Qiong Lei,et al.  Serum levels of the adipokine chemerin in preeclampsia , 2011, Journal of perinatal medicine.

[54]  K. Goralski,et al.  Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. , 2010, Endocrinology.

[55]  E. Podrez,et al.  Frontiers in Research Review: Physiological and Pathological Functions of High-Density Lipoprotein Anti-oxidant properties of high-density lipoprotein and atherosclerosis , 2010 .

[56]  G. Rice,et al.  Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. , 2010, Placenta.

[57]  W. Choi,et al.  Increased interaction between heat shock protein 27 and mitogen‐activated protein kinase (p38 and extracellular signal‐regulated kinase) in pre‐eclamptic placentas , 2009, The journal of obstetrics and gynaecology research.

[58]  J. Blangero,et al.  Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. , 2009, The Journal of clinical endocrinology and metabolism.

[59]  A. Shevchenko,et al.  Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.

[60]  R. Romero,et al.  Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women , 2007, Journal of perinatal medicine.

[61]  E. Butcher,et al.  Chemerin, a Novel Adipokine That Regulates Adipogenesis and Adipocyte Metabolism* , 2007, Journal of Biological Chemistry.

[62]  G. Nicocia,et al.  Adiponectin and insulin resistance in early‐ and late‐onset pre‐eclampsia , 2006, BJOG : an international journal of obstetrics and gynaecology.

[63]  R. Ness,et al.  Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. , 2005, American journal of epidemiology.

[64]  F. Casanueva,et al.  Expression and regulation of adiponectin and receptor in human and rat placenta. , 2005, The Journal of clinical endocrinology and metabolism.

[65]  L. Poston,et al.  Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. , 2004, Hypertension.

[66]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[67]  Y. Sang,et al.  Profiling Membrane Lipids in Plant Stress Responses , 2002, The Journal of Biological Chemistry.

[68]  P. Valet,et al.  Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis. , 2002, Journal of lipid research.

[69]  S. Smith.  Peroxisome proliferator-activated receptors and the regulation of mammalian lipid metabolism. , 2001, Biochemical Society transactions.

[70]  S. Djurovic,et al.  Dyslipidemia in early second trimester is mainly a feature of women with early onset pre‐eclampsia , 2001, BJOG : an international journal of obstetrics and gynaecology.

[71]  E. Gratacós.  Lipid-mediated endothelial dysfunction: a common factor to preeclampsia and chronic vascular disease. , 2000, European journal of obstetrics, gynecology, and reproductive biology.

[72]  T. Henriksen,et al.  Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. , 1999, American journal of obstetrics and gynecology.

[73]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.